Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Zai Lab Ltd | 393,750 | reported | 18 Jun 2025 | tx 9+70,602−7,852 |
| Syros Pharmaceuticals, Inc. | 16,000 | reported | 05 Jun 2024 | tx 12+136,500 |
| EPIX Pharmaceuticals, Inc. | 5,000 | reported | 26 May 2004 | tx 1+5,000 |
| GENZYME CORP | 0 | reported | 04 Apr 2011 | tx 43+744,396−1,493,504 |
| TRIMERIS INC | 0 | reported | 22 Jun 2015 | tx 6+30,000−30,000 |
| Forma Therapeutics Holdings, Inc., | 0 | reported | 14 Oct 2022 | tx 18+103,207−288,106 |
| ROFIN SINAR TECHNOLOGIES INC | 0 | reported | 07 Nov 2016 | tx 164+1,293,500−686,100 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 18 Jun 2025 | GRANT_AWARD | Zai Lab Ltd | 10,831 | 0.00 USD | |
| 18 Jun 2024 | GRANT_AWARD | Zai Lab Ltd | 21,253 | 0.00 USD | |
| 05 Jun 2024 | GRANT_AWARD | Syros Pharmaceuticals, Inc. | 4,000 | 0.00 USD | |
| 05 Jun 2024 | GRANT_AWARD | Syros Pharmaceuticals, Inc. | 6,000 | 0.00 USD | deriv |
| 29 Jun 2023 | GRANT_AWARD | Zai Lab Ltd | 18,903 | 26.45 USD | |
| 01 Jun 2023 | GRANT_AWARD | Syros Pharmaceuticals, Inc. | 4,000 | 0.00 USD | |
| 01 Jun 2023 | GRANT_AWARD | Syros Pharmaceuticals, Inc. | 6,000 | 0.00 USD | deriv |
| 08 Dec 2022 | SALE | Zai Lab Ltd | 4,000 | 35.33 USD | |
| 08 Dec 2022 | SALE | Zai Lab Ltd | 3,852 | 35.37 USD | |
| 14 Oct 2022 | TENDER | Forma Therapeutics Holdings, Inc., | 7,250 | — | |
| 14 Oct 2022 | TENDER | Forma Therapeutics Holdings, Inc., | 127,665 | — | |
| 14 Oct 2022 | OTHER | Forma Therapeutics Holdings, Inc., | 6,750 | — | deriv |
| 14 Oct 2022 | OTHER | Forma Therapeutics Holdings, Inc., | 8,375 | — | deriv |
| 14 Oct 2022 | OTHER | Forma Therapeutics Holdings, Inc., | 17,533 | — | deriv |
| 14 Oct 2022 | OTHER | Forma Therapeutics Holdings, Inc., | 28,053 | — | deriv |
| 14 Oct 2022 | OTHER | Forma Therapeutics Holdings, Inc., | 14,026 | — | deriv |
| 16 Sept 2022 | GRANT_AWARD | Syros Pharmaceuticals, Inc. | 8,000 | 0.00 USD | |
| 16 Sept 2022 | GRANT_AWARD | Syros Pharmaceuticals, Inc. | 12,000 | 0.00 USD | deriv |
| 08 Jun 2022 | GRANT_AWARD | Forma Therapeutics Holdings, Inc., | 4,500 | 0.00 USD | |
| 08 Jun 2022 | GRANT_AWARD | Forma Therapeutics Holdings, Inc., | 6,750 | 0.00 USD | deriv |
| 01 Jun 2022 | GRANT_AWARD | Syros Pharmaceuticals, Inc. | 17,500 | 0.00 USD | deriv |
| 03 Jan 2022 | GRANT_AWARD | Zai Lab Ltd | 7,763 | 0.00 USD | |
| 08 Dec 2021 | PURCHASE | Zai Lab Ltd | 4,000 | 71.36 USD | |
| 17 Jun 2021 | GRANT_AWARD | Forma Therapeutics Holdings, Inc., | 2,750 | 0.00 USD | |
| 17 Jun 2021 | GRANT_AWARD | Forma Therapeutics Holdings, Inc., | 8,375 | 0.00 USD | deriv |
3 purchases reported after at least 12 months of silence — most recent on 23 Jun 2020.